Hepatitis b breakthrough? study checks if bepirovirsen response lasts
NCT ID NCT04954859
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows about 360 people with chronic hepatitis B who had a good response to the experimental drug bepirovirsen in earlier trials. No new drug is given; researchers simply monitor whether the response lasts over time. Participants may or may not continue standard antiviral therapy. The goal is to see if a short treatment can lead to long-term disease control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could show that a short course of bepirovirsen leads to long-lasting control of hepatitis B without needing ongoing medication.
What could go wrong
This is an observational follow-up, not a new treatment test. It only includes people who already responded, so results may not apply to all hepatitis B patients. The number of participants is small, and long-term durability is uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Sacramento, California, 95817, United States
-
GSK Investigational Site
San Jose, California, 95128, United States
-
GSK Investigational Site
Colorado Springs, Colorado, 80907, United States
-
GSK Investigational Site
Boston, Massachusetts, 02114, United States
-
GSK Investigational Site
Detroit, Michigan, 48202, United States
-
GSK Investigational Site
La Plata, Buenos Aires, B1902AWL, Argentina
-
GSK Investigational Site
Buenos Aires, C1181ACH, Argentina
-
GSK Investigational Site
Buenos Aires, C1425AGC, Argentina
-
GSK Investigational Site
Rosario, 2000, Argentina
-
GSK Investigational Site
Santa Fe, 3000, Argentina
-
GSK Investigational Site
Herston, Queensland, 4029, Australia
-
GSK Investigational Site
Fitzroy, Victoria, 3065, Australia
-
GSK Investigational Site
Aracaju, Sergipe, 49055-000, Brazil
-
GSK Investigational Site
Campinas, 13060-803, Brazil
-
GSK Investigational Site
Curitiba, 30140-073, Brazil
-
GSK Investigational Site
Manaus, 69040000, Brazil
-
GSK Investigational Site
São Paulo, 05403-000, Brazil
-
GSK Investigational Site
Vila Mariana, 04121-000, Brazil
-
GSK Investigational Site
Plovdiv, 4000, Bulgaria
-
GSK Investigational Site
Sliven, 8800, Bulgaria
-
GSK Investigational Site
Sofia, 1431, Bulgaria
-
GSK Investigational Site
Sofia, 1463, Bulgaria
-
GSK Investigational Site
Sofia, 1606, Bulgaria
-
GSK Investigational Site
Varna, 9010, Bulgaria
-
GSK Investigational Site
Calgary, Alberta, T2N 4Z6, Canada
-
GSK Investigational Site
Victoria, British Columbia, V8R 6R3, Canada
-
GSK Investigational Site
Toronto, Ontario, M5G 2C4, Canada
-
GSK Investigational Site
Montreal, Quebec, H2X 0A9, Canada
-
GSK Investigational Site
Montreal, Quebec, H4A 3J1, Canada
-
GSK Investigational Site
Québec, Quebec, G1V 4G2, Canada
-
GSK Investigational Site
Beijing, 100015, China
-
GSK Investigational Site
Beijing, 100039, China
-
GSK Investigational Site
Beijing, 100050, China
-
GSK Investigational Site
Chengdu, 610041, China
-
GSK Investigational Site
Chengdu, 610072, China
-
GSK Investigational Site
Chongqing, 400042, China
-
GSK Investigational Site
Fuzhou, 350028, China
-
GSK Investigational Site
Guangzhou, 510000, China
-
GSK Investigational Site
Guangzhou, 510440, China
-
GSK Investigational Site
Guangzhou, 510630, China
-
GSK Investigational Site
Hangzhou, 310014, China
-
GSK Investigational Site
Hangzhou, 310022, China
-
GSK Investigational Site
Kunming, 650021, China
-
GSK Investigational Site
Liuzhou, China
-
GSK Investigational Site
Shanghai, 200025, China
-
GSK Investigational Site
Shanghai, 200040, China
-
GSK Investigational Site
Shanghai, 201508, China
-
GSK Investigational Site
Shenzhen, 518112, China
-
GSK Investigational Site
Tianjin, 300000, China
-
GSK Investigational Site
Ürümqi, 830054, China
-
GSK Investigational Site
Wuhan, 430030, China
-
GSK Investigational Site
Xi'an, 710061, China
-
GSK Investigational Site
Xiamen, 361015, China
-
GSK Investigational Site
Zhenjiang, China
-
GSK Investigational Site
Zunyi, 563114, China
-
GSK Investigational Site
Clichy, 92110, France
-
GSK Investigational Site
Lyon, 69317, France
-
GSK Investigational Site
Paris, France
-
GSK Investigational Site
Pessac, 33604, France
-
GSK Investigational Site
Rennes, 35000, France
-
GSK Investigational Site
Strasbourg, 67200, France
-
GSK Investigational Site
Düsseldorf, North Rhine-Westphalia, 40225, Germany
-
GSK Investigational Site
Berlin, 12157, Germany
-
GSK Investigational Site
Berlin, 12163, Germany
-
GSK Investigational Site
Frankfurt am Main, 60329, Germany
-
GSK Investigational Site
Hamburg, 20146, Germany
-
GSK Investigational Site
Athens, 10676, Greece
-
GSK Investigational Site
Athens, 11527, Greece
-
GSK Investigational Site
Heraklion, 711 10, Greece
-
GSK Investigational Site
Kowloon, Hong Kong
-
GSK Investigational Site
Pokfulam, Hong Kong
-
GSK Investigational Site
Budapest, 1097, Hungary
-
GSK Investigational Site
Belagavi, 590010, India
-
GSK Investigational Site
Coimbatore, 641005, India
-
GSK Investigational Site
Hyderabad, India
-
GSK Investigational Site
Kanchan Bagh Hyderabad, 40000, India
-
GSK Investigational Site
Mumbai, 400008, India
-
GSK Investigational Site
Mumbai, 400012, India
-
GSK Investigational Site
Mumbai, 400022, India
-
GSK Investigational Site
New Delhi, 110070, India
-
GSK Investigational Site
Pune, 411001, India
-
GSK Investigational Site
Surat, 395002, India
-
GSK Investigational Site
Bergamo, 24127, Italy
-
GSK Investigational Site
Milan, 20122, Italy
-
GSK Investigational Site
Milan, 20157, Italy
-
GSK Investigational Site
Modena, 40126, Italy
-
GSK Investigational Site
Naples, 80131, Italy
-
GSK Investigational Site
Palermo, 90127, Italy
-
GSK Investigational Site
Pisa, 56124, Italy
-
GSK Investigational Site
Gifu, 500-8717, Japan
-
GSK Investigational Site
Gifu, 503-8502, Japan
-
GSK Investigational Site
Hiroshima, 730-8619, Japan
-
GSK Investigational Site
Hiroshima, 734-8551, Japan
-
GSK Investigational Site
Hokkaido, 006-0811, Japan
-
GSK Investigational Site
Ishikawa, 920-8650, Japan
-
GSK Investigational Site
Kagawa, 760-8557, Japan
-
GSK Investigational Site
Kumamoto, 860-8556, Japan
-
GSK Investigational Site
Kumamoto, 862-8655, Japan
-
GSK Investigational Site
Miyagi, 980-8574, Japan
-
GSK Investigational Site
Niigata, 950-1104, Japan
-
GSK Investigational Site
Osaka, 565-0871, Japan
-
GSK Investigational Site
Tokyo, 113-8519, Japan
-
GSK Investigational Site
Tokyo, 113-8603, Japan
-
GSK Investigational Site
Tokyo, 180-8610, Japan
-
GSK Investigational Site
Yamaguchi, 750-0061, Japan
-
GSK Investigational Site
Kuala Terengganu, 20400, Malaysia
-
GSK Investigational Site
Auckland, 01042, New Zealand
-
GSK Investigational Site
Panama City, 7196, Panama
-
GSK Investigational Site
Cebu City, 6000, Philippines
-
GSK Investigational Site
Silang, 4118, Philippines
-
GSK Investigational Site
Gdansk, 80-405, Poland
-
GSK Investigational Site
Krakow, 31-202, Poland
-
GSK Investigational Site
Lublin, Poland
-
GSK Investigational Site
Mysłowice, 41-400, Poland
-
GSK Investigational Site
Żychlin, 62-571, Poland
-
GSK Investigational Site
Łańcut, 37-100, Poland
-
GSK Investigational Site
Bucharest, 020125, Romania
-
GSK Investigational Site
Bucharest, 021105, Romania
-
GSK Investigational Site
Bucharest, 030303, Romania
-
GSK Investigational Site
Craiova Dolj, 417307, Romania
-
GSK Investigational Site
Galati, 800179, Romania
-
GSK Investigational Site
Oradea, 410469, Romania
-
GSK Investigational Site
Chelyabinsk, 454052, Russia
-
GSK Investigational Site
Moscow, 121170, Russia
-
GSK Investigational Site
Novosibirsk, 630099, Russia
-
GSK Investigational Site
Saint Petersburg, 190103, Russia
-
GSK Investigational Site
Saint Petersburg, 191167, Russia
-
GSK Investigational Site
Samara, 443063, Russia
-
GSK Investigational Site
Красноярск, 660049, Russia
-
GSK Investigational Site
Singapore, 119074, Singapore
-
GSK Investigational Site
Singapore, 169608, Singapore
-
GSK Investigational Site
Singapore, 529889, Singapore
-
GSK Investigational Site
Durban, 4091, South Africa
-
GSK Investigational Site
Johannesburg, 1830, South Africa
-
GSK Investigational Site
Ansan-si Gyenggi-do, 15355, South Korea
-
GSK Investigational Site
Busan, 47392, South Korea
-
GSK Investigational Site
Pusan, 49241, South Korea
-
GSK Investigational Site
Seoul, 03312, South Korea
-
GSK Investigational Site
Seoul, 05505, South Korea
-
GSK Investigational Site
Seoul, 08308, South Korea
-
GSK Investigational Site
HebrOn, 08035, Spain
-
GSK Investigational Site
León, 24080, Spain
-
GSK Investigational Site
Madrid, 28031, Spain
-
GSK Investigational Site
Santander, 39008, Spain
-
GSK Investigational Site
Valencia, 46026, Spain
-
GSK Investigational Site
Vigo, 36071, Spain
-
GSK Investigational Site
Kaohsiung City, 807, Taiwan
-
GSK Investigational Site
Kaohsiung City, 824, Taiwan
-
GSK Investigational Site
Kaohsiung City, 833, Taiwan
-
GSK Investigational Site
Taichung, 40447, Taiwan
-
GSK Investigational Site
Tainan, 70403, Taiwan
-
GSK Investigational Site
Taipei, 10002, Taiwan
-
GSK Investigational Site
Taipei County, 104, Taiwan
-
GSK Investigational Site
Taoyuan, 333, Taiwan
-
GSK Investigational Site
Bangkok, 10330, Thailand
-
GSK Investigational Site
Bangkok, 10400, Thailand
-
GSK Investigational Site
Chiang Mai, 50200, Thailand
-
GSK Investigational Site
Kho Hong Hat Yai, 90110, Thailand
-
GSK Investigational Site
Cottingham, HU16 5JQ, United Kingdom
-
GSK Investigational Site
Liverpool, L7 8XP, United Kingdom
-
GSK Investigational Site
London, SW9 8RR, United Kingdom
-
GSK Investigational Site
London, WC1E 6JB, United Kingdom
-
GSK Investigational Site
Plymouth, PL68DH, United Kingdom